Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is this the study that was reported as not going to be out until 2018, a portion of the 2018 report, or a different one?
http://www.crossroadstoday.com/story/35055551/cannabics-pharmaceuticals-inc-receives-the-final-report-of-its-research-on-antitumor-properties-of-cannabinoids-held-in-israel
YES!! Report is attached: Cannabics Pharmaceuticals Inc. Receives the Final Report of Its Research on Antitumor Properties of Cannabinoids Held in Israel
http://finance.yahoo.com/news/cannabics-pharmaceuticals-inc-receives-final-130000674.html
Just an observation of the repetitiveness of the 423,423.
Funny you would mention that. I had not noticed the 37%, but was going to mention 40% acquisition as an example in my previous post. Not far off!
At 4pm, the bid quantity was 423,423. :)
You may be right, but in my experience, when a bigger company helps a smaller company, they usually acquire a percentage of the smaller company for their trouble. I could very well be wrong in this instance, but as you said, any help would be great!
Reading over posts & questions on PR's, if Aurora did approach VDRM, this may explain why there has been a complete news black out since the conference.
If they are talking, Aurora would have sworn everyone to secrecy until an agreed upon time, so acquisition talks may be the reason we haven't heard a peep from Otiko.
Just a thought as I read over the posts here and at Aurora's board, where posters are discussing the same thing.
With proper auditing they should be able to confirm their financials.
You are welcome good sir!
Found a nice album of DFCON 2017 pics:
https://myalbum.com/album/vPmijJ732YOz
Gives an idea of the level they go to in the presentations, etc.
Thanks, Jim
If they wouldn't allow him to film a quick clip of himself, then I can understand it. But a lot of the stuff I go to is invite only, pay to play, and you still see it on the company facebook that they attended with a quick clip about how things are going, etc. For Otiko, this was that opportunity.
YES!! Thank you GreenBrickRoad for getting it!!
What would be confidential? Maybe this industry doesn't do this, but I think for a small company that had one big piece of news for the month of March, they should have thought to do some form of interview about participating in the conference.
I just question the missed opportunity of it.
RE: A video interview from the conference: I should have been more clear about stating that I feel Otiko should have done this to promote himself. In this day and age of everyone having a video camera and camera on their phone, people at conferences and conventions that want to get the word out about their product will often do interviews to promote themselves as well as answer questions.
They do this at the conference, with their banner/poster behind them, because "coming to you live from the DFCON conference" with the production value of a lot of people in attendance and the set up of a booth etc lends itself to showing that you have a product to sell and creates an image of activity, compared to just filming an interview sitting at a desk in an office.
I am surprised we are not seeing any form of advertising like this. I am not someone that expects to see a new PR everyday as another person commented, but this conference has been the big deal on the VDRM horizon for some time and it would have been an inexpensive, low tech way to get news about VDRM and Otiko in front of possible investors.
This convention compared to another industry I'm in:
This is not off topic, stick with me here.
This past weekend was the world's largest Halloween & Haunted Attraction Trade Show, held in St. Louis, Missouri. http://www.haashow.com/
Keep in mind, the show is invitation only. You have to prove you are part of the Halloween Industry (haunt owner, store owner, etc) to get invited to buy so as to minimize "gawker traffic" and so stores can sell at a mark up.
Over the weekend you could get live feeds, up to date info, photos, videos, information about every vendor, the location of their booth, interviews with the owners. All of this for an invite only event.
This show, this industry, wants to sell, and they use social media to stir up interest and get haunted attraction owners and stores like Spirit Halloween to request permission to come from all over the world to purchase products for the coming Halloween season.
Why did DFCON not do anything like this? Where are the live streams, the invterviews? Not just Otiko, the conference/convention itself?
Why have we not seen Youtube videos? Why is there so few photos, etc?
I have spoken at conferences/conventions. While speaking, an official conference photographer slips in and gets photos and video of your lecture for their advertising. Why not at DFCON?
All products come down to desire to sell and desire to buy. Why is DFCON not creating a buzz so that doctors want to attend next year?
"We're having this great show... and we're going to make sure it has a media black out... enjoy!!".
Doesn't make sense. Please, not just Otiko, get us video of the presentations and conference.
Thanks, Jim
Not sure where you are getting your DD but CNBX has never been a sub-penny stock. An "All Time" search shows that.
As for "7 months ago", here is the 52 week as of today:
0.02 - 7.60
Last summer is when it hit .02, but it has never been a sub-penny stock.
The reason CNBX is where it is now is that it has legitimate product in the market that can show a track record (Wana Caps RX for one).
The reason it is not higher is the OTC Board released the same "Warning" they have done to other companies to chill the price and keep CNBX from jumping to a bigger board when it was at $ 7.60.
My sell ticket for CNBX is in at $ 10. When I placed it I was advised the next year will see it at $ 20, but my technique is to collect and move on while stocks are still on the rise to guarantee I get my price and can get on to the next one.
Take care, Jim
Thanks, I am in that as well.
He couldn't win because of the rules posted.
Presenters like Otiko were not up to win Abstracts. Abstracts are for people like professors who dedicate their lives to studying some facet of health care.
As I noted, no one working for a health care company could win. No one promoting a specific product could win. His not winning is not a negative, as he was never up for winning for Abstract.
Not viable for Abstract Winner for following reasons:
1. The presenting author cannot be an employee of a company that develops health care products or provides health care services.
2. Abstracts cannot contain product names; generic terms must be used when describing a single product.
Abstracts are where someone that has done a study can present their findings.
They cannot work in health care, own or work for a company in health care, and cannot be promoting a particular product.
Reasons Israel Is Relevant To Cannabics (CNBX):
(The reasons listed are tied to each other and get more relevant to CNBX as you go).
1. Unlike "Merica", that can't get its head out of its ass about anything, Israel's Ministry of Health sees the benefits of cannabis usage and has cleared the way for major cannabis studies.
2. Israel, last I heard, is the only country that has not only cleared the hurdle above, but has also been cleared to import biopsies and export its findings and cannabis based products globally.
3. Israel has licensed CNBX in particular to do biopsy studies on biopsies provided by physicians and hospitals from around the world, and in turn, CNBX is one of the very few companies with Israeli Ministry of Health backing to accept and provide such a service and such studies. In short, Israel is the only one allowed to currently act globally, and they chose CNBX to do the studies.
4. Unlike so many other companies that are still trying to raise enough money for a good website, CNBX actually has multiple products on the market, including WANA CAPS out of Colorado, a 5MG THC capsule that is being prescribed specifically to patients that have never used cannabis treatment before, and the liquid biopsy product that can be made specific to cancer patients and in turn provide specific data to that patient and in turn specific treatment to that patient.
5. Apart from all of the good listed above, CNBX is the only company with a slow release 12 hour pill. Other companies have various edibles, sprays, etc. Why is a 12 hour pill important? After the medical marijuana battle is over in the government, the next battle is to get doctors and patients to accept medical marijuana. The more like regular medicine, the more apt patients and doctors are to accept it.
6. The next major reason a 12 hour long release pill is important: Even after the government, doctors, and patients have accepted medical marijuana, employers can still ban marijuana from being brought into their businesses. The best way around that is to have a pill you can take before and after work, hence the importance of a 12 hour long release capsule. When you don't want to eat brownies, smoke, or have a spray leaking inside your purse or briefcase, the use of a pill will quickly take over the most accepted form of medical marijuana.
I could go on, but the half dozen reasons above show why Israel is playing a huge role in medical marijuana, and their choosing CNBX to be one of their main researchers is why this stock jumped from .03 last summer to where it is now.
The only reason it is not higher is because the OTC Board did not want to see CNBX leave and go to the higher dollar boards and floated a "we're watching you" warning regarding the sudden rise in stock price simply to scare investors and bring the price back down. That is what brought CNBX down from $ 7.60, and they have done the exact same thing to other companies that were breaking out. There are a lot of books you can buy on how trading boards play dirty, but suffice it to say, the scare tactic worked to a point but the stock has still jumped from .03 to around 3.00 for a reason.
You can find what I have provided above at various sites and in various articles, many of which are out of Israel and are not CNBX public relation material. I have been studying CNBX since early 2015 and have been in it since July 2015. There are a lot of stocks out there, but this one has the Israeli Ministry of Health as a pedigree and actual products selling in various areas.
Check out http://www.wanacaps.com/home They are selling CNBX products under their Wana brand in Colorado, and I believe Washington, Oregon, and possibly Nevada. The list is growing with the number of states that legalized November 2016.
Take care, Jim
CNBX in "6 Pot Stocks Set To Surge", a nice "Street Register" article from March 18th.
http://streetregister.com/2017/03/18/recent-developments-in-cannabics-pharmaceuticals-inc-otcmkts-cnbx-could-push-shares-higher/
Does anyone have video from the conference?
If so, please post!!
Moderators, if anyone posts video, please make it a "sticky" at the top of the posts so it doesn't get lost.
Thank You!! Jim
"However, even at this stage, the announcement of a definitive agreement is sure to once again trigger a surge in the stock".
Article pasted below:
http://mmjreporter.com/marijuana-company-of-america-inc-otcmktsmcoa-declines-as-update-on-definitive-agreement-still-awaited-2698.html
Is there up to date info on membership numbers, orders, etc?
My main interest is number of members, growth of membership over X amount of time, and number of orders they place.
If anyone can direct me to up to date, actual numbers, I appreciate it.
Thank you, Jim
Is there a reason this is green today despite all the doom and gloom talk?
Thanks, Jim
VDRM heading to Canada, eh! Marketwatch Article below:
http://www.marketwatch.com/story/viaderma-receives-provisional-patent-numbers-for-its-fda-registered-viabecline-and-cannabis-technologies-and-seeks-to-distribute-its-products-with-a-management-marketing-and-distribution-company-in-canada-to-approved-international-cannabis-countries-2017-03-20
CNBX gets a positive mention in another article:
http://m.benzinga.com/article/9183591
From Yahoo Finance: "ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline".
http://finance.yahoo.com/news/viaderma-receives-provisional-patent-numbers-120000445.html
Stock will be manipulated to hit between $4 to $7 again at least one more time as soon as possible as they will want to get their new "advisers" paid, and they pay them with stock that appreciates.
Whether by PR or some other means, they will get themselves paid.
It may not last long, so if you want to sell off at anywhere near those prices, I would put in a standing limit ticket.
If this ship is not sinking and they get some traction from the biopsy business they started this month, great.
If the ship is sinking, they will create an opportunity to get the new people paid.
You're the second person to mention $10 to me in the past month.
Do you have a thought on when it may be in that range?
When I get comparable numbers, I like to compare the time frame as well.
Thanks, Jim
I am hoping that VDRM makes up for any headaches CNB* gives us. I have a little over 187,000 shares of VDRM now and if I liquidate my 33,000 shares of CNB* I will probably put part of the proceeds into VDRM.
When you finished your post about the 5 million cap and it being a joke, did you mean VDRM or CNB*?
Looking to free up some $$$ next week ahead of the convention and be in a position to buy.
Take care, Jim
Thank you clicktock. Was asking beyond what we have in the report you posted and the other regularly posted info(clinicals.gov, Cannatech next week) if anyone had anything that had not been mentioned recently.
I greatly appreciate your posts and I have read both your posts as well as the official report. I figured I would ask if anyone had any other data.
Thank you, Jim
RE: #1413, Can anyone provide substantial support in favor of staying in CNBX?
I have been in it since July 2015, and have believed in it, including the recent biopsy clinicals. But a message like the one given by the auditors seems a bit too specific to CNBX. More than the typical forward looking statement notices.
I know about the positive possibilities regarding clinicals.gov, the conference next week, etc. But beyond that, does anyone have some substantial support (not just "rah rah") to justify staying with CNBX? I got in between .03 to .15. Kind of hate to wake up and find it back there.
Please advise if anyone has something to support staying in.
Thank You, Jim
Stock mentioned (CNB*) was at .03 last summer and $ 7 last month. I would be very happy if VDRM does the same.
Biopsies began last Friday (3/10) and the effects on the stock price will be based on:
1. How many physicians/hospitals send biopsies to CNBX to be tested.
2. The results of the effects of CNBX on the biopsies.
So, based on how many and how soon biopsies are provided for the study, we will have a report on the outcome.
The chances for a positive outcome are high based on preliminary tests before the offer was made to have biopsies sent in.
In short, we could have news as early as yet this month (March 2017) or in April. The addition of board members was made in part due to this escalation of activity and to be in a position to move forward based on the results.
Having studied CNBX since early 2015, this is the most activity I have seen within the company.
Jim
What Insider Financial said about VDRM Feb. 22nd:
https://www.insiderfinancial.com/viaderma-inc-otcmktsvdrm-is-one-we-keep-coming-back-to/119728/
The good news about new advisers: As long as it is not a reshuffling of friends that were already invested simply to create news; if these advisers are truly new to CNBX, they are going to want compensated for their time.
When a company is low on funds, stock is how you compensate new people. No one is going to want compensated with a stock that is flat lining or going down, so once new people are brought in, everything the company can possibly do to pump up the stock price is going to be done to get these people paid.
Even for the most negative ones among us, follow the money, and realize that if they are going to take measures to raise stock price, even for a brief time, it helps us all.
I am hoping that if for no other reason than compensation, we will see $ 6 plus again soon.
How long the price stays up depends on what measures they take and what positives (PR releases on clinicals, Cannatech, etc) follow/accompany the measures.
Take care, Jim
Current ASK for CNBX on Etrade is $800 for 1 share. Someone is either trying to be funny or salt the tip jar!!! (Pasted below).
I am placing my limits for tomorrow and when I entered for CNBX, it showed me the current Bid and Ask. $ 800 ????
CANNABICS PHARMACEUTICALS INC COM
CNBX:NSDQ
Last Price
Today's Change
Volume
2.954
-0.016(-0.54%)
1,122,501
Bid (Size) $ 0.0001(10000)
Ask (Size) $ 800.00(1)
3 articles in the last hour. Good news. Sessions is in hot water. 3 separate articles below:
https://www.washingtonpost.com/world/national-security/sessions-spoke-twice-with-russian-ambassador-during-trumps-presidential-campaign-justice-officials-say/2017/03/01/77205eda-feac-11e6-99b4-9e613afeb09f_story.html
http://thehill.com/blogs/blog-briefing-room/news/321930-sessions-spoke-with-russian-ambassador-during-trumps-campaign
http://www.reuters.com/article/us-usa-trump-russia-sessions-idUSKBN16908L?il=0
3 articles in the last hour. Good news. Sessions is in hot water. 3 separate articles below:
https://www.washingtonpost.com/world/national-security/sessions-spoke-twice-with-russian-ambassador-during-trumps-presidential-campaign-justice-officials-say/2017/03/01/77205eda-feac-11e6-99b4-9e613afeb09f_story.html
http://thehill.com/blogs/blog-briefing-room/news/321930-sessions-spoke-with-russian-ambassador-during-trumps-campaign
http://www.reuters.com/article/us-usa-trump-russia-sessions-idUSKBN16908L?il=0